Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.39
- Piotroski Score 2.00
- Grade Buy
- Symbol (RANI)
- Company Rani Therapeutics Holdings, Inc.
- Price $2.04
- Changes Percentage (-10.13%)
- Change -$0.23
- Day Low $2.00
- Day High $2.29
- Year High $8.75
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I clinical trial for the treatment of neuroendocrine tumors and acromegaly; RT-105, an anti-TNF-alpha antibody to treat psoriatic arthritis; RT-102, a parathyroid hormone that is in preclinical studies for the treatment of osteoporosis; RT-109, a human growth hormone to treat growth hormone deficiency; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-106, a basal insulin for the treatment of type 2 diabetes. The company was incorporated in 2012 and is headquartered in San Jose, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/13/2024
- Fiscal Year End N/A
- Average Stock Price Target $10.00
- High Stock Price Target $28.00
- Low Stock Price Target $9.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.29
- Trailing P/E Ratio -3.4
- Forward P/E Ratio -3.4
- P/E Growth -3.4
- Net Income $-33,970,000
Income Statement
Quarterly
Annual
Latest News of RANI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Rick Moranis Takes a Stroll in N.Y.C. During Rare Public Outing After Leaving Hollywood
Beloved actor Rick Moranis, known for classic movies, was spotted in Manhattan. Moranis took a hiatus from Hollywood to raise his kids after his wife's death....
By PEOPLE.com | 1 day ago -
Iranian official met with Musk in a possible step to ease tensions with Trump
Iran sought a meeting with Elon Musk to ease tensions with President-elect Donald Trump. The discussion covered Iran's nuclear program, anti-Israel support, and prospects for improved U.S. relations. ...
By AP NEWS | 3 days ago -
Top Iranian adviser visits Lebanon for high-stakes war negotiations
Iran's top adviser visited Lebanon amid Israel-Hezbollah tensions, pledging support. US mediates peace talks. Elon Musk meets Iran's UN Ambassador to ease US-Iran tensions. UN Security Council drafts ...
By Newsweek | 3 days ago
